Keywords: biogen, idec/vernalis, initiate, ph, ii, trials, novel

Biogen Idec/Vernalis initiate two Ph II trials of novel PD drug

Article | 14 May 2007

Print This

US drugmaker Biogen Idec has initiated a Phase II program of BIIB014 (also known as V2006), an oral compound co-developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in